SEARCH RESULTS FOR: 新闻总览打包安卓app要多少钱(电报e86e86)网址转安卓APP.qgk(2377 results)

ASSURE patient app is a component of CareStation.

SW APP A71200 SCS CLINICIAN NG PAIN PC

SW APP A72400 SCS CLINICIAN PP NG RC

SW APP A71400 SCS CLINICIAN CP NG RC

SW APP A72200 SCS PATIENT NG PAIN PC

SW APP A820 TDD PATIENT PROG V2.X

SW APP A810 TDD CLINICIAN PROG V2.X

Software, Sonicare Power Tooth brush, Web download App Android

Software, Sonicare Power Tooth brush, Web download App iOS

Pressure PreventionBlank Product Description: Balanced Aire APP Mattress Custom

DreamMapper Mobile App Android, North America Instance, version 2.17

DreamMapper Mobile App Android, Asia- Pacific Instance, version 2.17

Hygieia d-Nav System Phone App - Apple iOS Operating System

1, Needle App 18ga x 20cm Brachytherapy Non-Waxed, St

WAG Premium Arm GEN5 No Qualcomm/Homedics BT App

DBD-PUMP, APP W/PAD, AERO PULSE, 31" X 6

Tampons, Retail, App. Reg.25/Super 10/Super+ 10

SPRAY SET ENDOSCOPIC APP. 5MMX40 CM, 11:1 RATIO

SPRAY SET ENDOSCOPIC APP. 5MMX30 CM, 11:1 RATIO

US Dexcom Follow App for iOS, (mg/dL), v4

US Dexcom Follow App for Android (mg/dL), v4

Wireless Endoscopic Camera System with Wifi, 1080p, Endovision App, White

Med Aire Assure 5" Air + 3" Foam APP and LAL

STRPR 1.2 APP, LINKED BL STREAMER PRO 1.2 NO LOGO

STRPR 1.2 APP, LINKED WH STREAMER PRO 1.2 NO LOGO

MEGA-AMZ-TAMP-1 - FLO Organic Cotton App Tampons Regular Pack (80 Tampons)

Meridian Medical APP System - adjustable pump and single layer pad

Cora Tampons, DTC, App. Light 5/Reg. 6/Super 5

SPRAY SET ENDOSCOPIC APP. 5MM, 40 CM, 1:1 RATIO

For the wireless mode version of the subject device, combined with an application installed on a tablet that can be used in a home environment, the content of the SPM01K4 convenience kit is: 1 electrostimulator SPM01M1 configuration; electrodes; protective skin, and 1 tablet with the MySPM@Home mobile application (SPM01A2).

No Description

No Description

No Description

No Description

reSET-O® Mobile Application running on Android. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

reSET-O® Mobile Application running on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

reSET® Mobile Application running on Android. reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12 week (90 days) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: - increase abstinence from a patient’s substances of abuse during treatment, and - increase retention in the outpatient treatment program.

reSET® Mobile Application running on iOS. reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12 week (90 days) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: - increase abstinence from a patient’s substances of abuse during treatment, and - increase retention in the outpatient treatment program.

DreamMapper Android APAC Instance v 2.11

DreamMapper Android NA Instance v 2.11

DreamMapper Android APAC Instance v 2.10

DreamMapper Android NA Instance v 2.10

DreamMapper Mobile Application Android (EMEA)

DreamMapper Android APAC Instance v 2.13

DreamMapper Android EU Instance v 2.13

DreamMapper Android NA Instance v 2.13

DreamMapper Android EU Instance v 2.11

DreamMapper Android EU Instance v 2.10

No Description

Eko mobile app for android international platforms for use with Eko medical devices.